Vacinação contra o papilomavírus humano como estratégia adjuvante ao tratamento de lesão escamosa intraepitelial de alto grau cervical em colo uterino
DOI:
https://doi.org/10.5327/2237-4574-235Resumo
***
Referências
American College of Obstetricians and Gynecologists. Human Papillomavirus
Vaccination: Practice Bulletin No. 206. Obstet Gynecol. 2019;134(4):e128-43.
Perkins RB, Guido R, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019
ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer
Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102-31.
https://doi.org/10.1097/lgt.0000000000000525
International Federation of Gynecology and Obstetrics (FIGO). FIGO Statement on
HPV Vaccination and Cervical Cancer Prevention. Int J Gynaecol Obstet.
;152(2):281-2.
Del Pino M, Alemany L, Quint W, Clavel C, Ordi J, Tous S, et al. Efficacy of HPV
Vaccination on Women Undergoing Excisional Treatment for Cervical Intraepithelial
Neoplasia: A Systematic Review and Meta-Analysis. Lancet Oncol. 2020;21(4):552-71.
Roteli-Martins CM, Magno V, Santos ALF, Teixeira JC, Nilma AN, Fialho SCAV.
HPV vaccination for adult women. Rev Bras Ginecol Obstet. 2022;44(6):631-5.